SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-016570
Filing Date
2024-06-12
Accepted
2024-06-12 20:00:08
Documents
1
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 form4-06122024_080605.html 4  
1 form4-06122024_080605.xml 4 6091
  Complete submission text file 0001415889-24-016570.txt   7622
Mailing Address 3 COLUMBUS CIRCLE, SUITE 1710 C/O ARALEZ PHARMACEUTICALS INC. NEW YORK NY 10019
Business Address
KOVEN ANDREW I (Reporting) CIK: 0001258673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 241039760

Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Issuer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)